Pharma Focus DistillerSR already serves a broad base of leading pharma and medical device companies and hundreds of research organizations, indicating strong incumbency and significant upsell potential within large accounts. Opportunities include expanding adoption of automated evidence review and library services within these customers, particularly to support regulatory submissions and policy guidelines.

Regulatory Ready Recent regulatory-oriented features such as EU-MDR workflow templates and PRISMA guidance support demonstrate a clear value proposition for regulatory teams across regions. Sales opportunities exist in targeting pharma, device, and CRO customers needing compliant literature reviews, accelerated regulatory submissions, and audit-ready documentation.

Automation Growth New fully automated capabilities for the Smart Evidence Extraction module and advanced evidence management features position DistillerSR to sell higher-value automation packages to research labs, CROs, and academic institutions seeking faster, reproducible literature reviews.

Global Expansion Global expansion signals, with EU-focused templates and library services, suggest growth opportunities in Europe and other regulated markets. There is potential to partner with CRO networks, universities, and government research bodies, and to leverage existing technology integrations (Salesforce CPQ, Angular/Node.js stack) to fit client IT ecosystems.

Services Upsell DistillerSR offers library services, CuratorCR modules, and AI training, enabling a services-led upsell alongside software licenses. Target customers with ongoing needs for workflow optimization, evidence management, and training to drive recurring revenue and long-term retention.